The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
The Caco-2 cell monolayer: usefulness and limitations
Abstract
BACKGROUND: The Caco-2 monolayer has been used extensively for the high-throughput screening of drug permeability and identification of substrates, inhibitors, and inducers of intestinal transporters, especially P-glycoprotein (P-gp). Traditionally, the Caco-2 monolayer is viewed as a single barrier rather than a polarized cell monolayer consisting of metabolic enzymes that are sandwiched between two membrane barriers with distinctly different transporters. OBJECTIVE: This review addressed the usefulness and limitations of the Caco-2 cell monolayer in drug discovery and mechanistic studies. METHODS: This mini-review covered applications of the Caco-2 monolayer, clarified misconceptions, and critically addressed issues on data interpretation. CONCLUSION: The catenary model extends the usefulness of Caco-2 monolayer and provides proper mechanistic insight and data interpretation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hidalgo, I. J., Raub, T. J., & Borchardt, R. T. (1989) · Gastroenterology · doi:10.1016/s0016-5085(89)80072-1 · Cited by 2,396
Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers
Hubatsch, I., Ragnarsson, E. G. E., & Artursson, P. (2007) · Nature Protocols · doi:10.1038/nprot.2007.303 · Cited by 1,499
Kim, R. B., Fromm, M. F., Wandel, C., Leake, B., Wood, A. J., Roden, D. M., & Wilkinson, G. R. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1269 · Cited by 1,054
Yee, S. (1997) · Pharmaceutical Research · doi:10.1023/a:1012102522787 · Cited by 1,030
Allen, J. D., van Loevezijn, A., Rademaker-Lakhai, J. M., van der Valk, M., van Tellingen, O., Reid, G., Schellens, J. H. M., Koomen, G., & Schinkel, A. H. (2002) · PubMed · Cited by 814
Rational Use of in Vitro P-glycoprotein Assays in Drug Discovery
Polli, J. W., Wring, S. A., Humphreys, J. E., Huang, L., Morgan, J. B., Webster, L. O., & Serabjit-Singh, C. S. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29270-3 · Cited by 662
Caco-2 Cell Monolayers as a Model for Drug Transport Across the Intestinal Mucosa
Hilgers, A. R., Conradi, R. A., & Burton, P. S. (1990) · Pharmaceutical Research · doi:10.1023/a:1015937605100 · Cited by 587
Hilgendorf, C., Ahlin, G., Seithel, A., Artursson, P., Ungell, A.-L., & Karlsson, J. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.014902 · Cited by 583
Effect of Chitosan on Epithelial Cell Tight Junctions
Smith, J., Wood, E., & Dornish, M. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000012150.60180.e3 · Cited by 467
Sun, D., Lennernas, H., Welage, L. S., Barnett, J. L., Landowski, C. P., Foster, D., Fleisher, D., Lee, K.-D., & Amidon, G. L. (2002) · Pharmaceutical Research · doi:10.1023/a:1020483911355 · Cited by 447
Gekeler, V., Ise, W., Sanders, K. H., Ulrich, W. R., & Beck, J. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1344 · Cited by 396
Hunter, J., Jepson, M. A., Tsuruo, T., Simmons, N. L., & Hirst, B. H. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82429-2 · Cited by 370
Englund, G., Rorsman, F., Rönnblom, A., Karlbom, U., Lazorova, L., Gråsjö, J., Kindmark, A., & Artursson, P. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.04.010 · Cited by 368
Lindmark, T., Kimura, Y., & Artursson, P. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37216-7 · Cited by 333
Transcriptional Control of Intestinal Cytochrome P-4503A by 1α,25-Dihydroxy Vitamin D3
Thummel, K. E., Brimer, C., Yasuda, K., Thottassery, J., Senn, T., Lin, Y., Ishizuka, H., Kharasch, E., Schuetz, J., & Schuetz, E. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.6.1399 · Cited by 325
Schmiedlin-Ren, P., Thummel, K. E., Fisher, J. M., Paine, M. F., Lown, K. S., & Watkins, P. B. (1997) · Molecular Pharmacology · doi:10.1124/mol.51.5.741 · Cited by 325
Reversal of resistance by GF120918 in cell lines expressing the ABC half-transporter, MXR
de Bruin, M., Miyake, K., Litman, T., Robey, R., & Bates, S. E. (1999) · Cancer Letters · doi:10.1016/s0304-3835(99)00182-2 · Cited by 298
Lennernäs, H., Palm, K., Fagerholm, U., & Artursson, P. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)04204-0 · Cited by 274
Ohashi, R., Tamai, I., Yabuuchi, H., Nezu, J.-I., Oku, A., Sai, Y., Shimane, M., & Tsuji, A. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35167-5 · Cited by 273
Rautio, J., Humphreys, J. E., Webster, L. O., Balakrishnan, A., Keogh, J. P., Kunta, J. R., Serabjit-Singh, C. J., & Polli, J. W. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.008615 · Cited by 260
MDR- and CYP3A4-mediated drug–herbal interactions
Pal, D., & Mitra, A. K. (2006) · Life Sciences · doi:10.1016/j.lfs.2005.12.010 · Cited by 254
Chen, F., Ma, L., Dawson, P. A., Sinal, C. J., Sehayek, E., Gonzalez, F. J., Breslow, J., Ananthanarayanan, M., & Shneider, B. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207903200 · Cited by 253
Watson, C. J., Rowland, M., & Warhurst, G. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.281.2.c388 · Cited by 250
Bile acid-induced negative feedback regulation of the human ileal bile acid transporter
Neimark, E., Chen, F., Li, X., & Shneider, B. L. (2004) · Hepatology · doi:10.1002/hep.20295 · Cited by 234
Strategies for Absorption Screening in Drug Discovery and Development
Bohets, H., Annaert, P., Mannens, G., van Beijsterveldt, L., Anciaux, K., Verboven, P., Meuldermans, W., & Lavrijsen, K. (2001) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026013394886 · Cited by 230
Human Jejunal Effective Permeability and Its Correlation with Preclinical Drug Absorption Models
LennernÄs, H. (1997) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1997.tb06084.x · Cited by 223
Are MDCK Cells Transfected with the Human MDR1 Gene a Good Model of the Human Intestinal Mucosa?
Tang, F., Horie, K., & Borchardt, R. T. (2002) · Pharmaceutical Research · doi:10.1023/a:1016140429238 · Cited by 213
Comparative Studies on in Vitro Methods for Evaluating in Vivo Function of MDR1 P-Glycoprotein
Adachi, Y., Suzuki, H., & Sugiyama, Y. (2001) · Pharmaceutical Research · doi:10.1023/a:1013358126640 · Cited by 195
Hirohashi, T., Suzuki, H., Chu, X.-Y., Tamai, I., Tsuji, A., & Sugiyama, Y. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35286-3 · Cited by 192
Artursson, P., & Magnusson, C. (1990) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600790710 · Cited by 183
Participation of a Proton-Cotransporter, MCT1, in the Intestinal Transport of Monocarboxylic Acids
Tamai, I., Takanaga, H., Ogihara, T., Higashida, H., Maeda, H., Sai, Y., & Tsuji, A. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2312 · Cited by 181
Mechanism(s) of butyrate transport in Caco-2 cells: role of monocarboxylate transporter 1
Hadjiagapiou, C., Schmidt, L., Dudeja, P. K., Layden, T. J., & Ramaswamy, K. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.279.4.g775 · Cited by 181
Palm, K., Luthman, K., Ros, J., Gråsjö, J., & Artursson, P. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35123-7 · Cited by 173
Prediction of intestinal absorption: comparative assessment of gastroplus™ and idea™
Parrott, N., & Lavé, T. (2002) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00132-x · Cited by 170
Sai, Y., Kaneko, Y., Ito, S., Mitsuoka, K., Kato, Y., Tamai, I., Artursson, P., & Tsuji, A. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.009530 · Cited by 168
GIESSMANN, T., MAY, K., MODESS, C., WEGNER, D., HECKER, U., ZSCHIESCHE, M., DAZERT, P., GRUBE, M., SCHROEDER, E., & WARZOK, R. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.04.011 · Cited by 167
Role Reversal for Anticancer Agents
Pardee, A. B. (2002) · Cancer Biology & Therapy · doi:10.4161/cbt.1.4.22 · Cited by 165
Anderberg, E. K., & Artursson, P. (1993) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600820412 · Cited by 164
Troutman, M. D., & Thakker, D. R. (2003) · Pharmaceutical Research · doi:10.1023/a:1025001131513 · Cited by 159
Troutman, M. D., & Thakker, D. R. (2003) · Pharmaceutical Research · doi:10.1023/a:1025049014674 · Cited by 154
Kinetic Profiling of P-glycoprotein-Mediated Drug Efflux in Rat and Human Intestinal Epithelia
Stephens, R. H., O’Neill, C. A., Warhurst, A., et al. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38782-8 · Cited by 149
Exploring the Role of Different Drug Transport Routes in Permeability Screening
Matsson, P., Bergström, C. A. S., Nagahara, N., Tavelin, S., Norinder, U., & Artursson, P. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049711o · Cited by 147
Prime-Chapman, H. M., Fearn, R. A., Cooper, A. E., Moore, V., & Hirst, B. H. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.068775 · Cited by 140
Modulation of P‐glycoprotein but not MRP1‐ or BCRP‐mediated drug resistance by LY335979
Shepard, R. L., Cao, J., Starling, J. J., & Dantzig, A. H. (2002) · International Journal of Cancer · doi:10.1002/ijc.10792 · Cited by 138
Transport of bile acids in a human intestinal epithelial cell line, Caco-2
Hidalgo, I. J., & BORCHARDT, R. T. (1990) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(90)90179-z · Cited by 137
Pfrunder, A., Gutmann, H., Beglinger, C., & Drewe, J. (2003) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2003.tb02434.x · Cited by 134
Ebert, B., Seidel, A., & Lampen, A. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfl147 · Cited by 129
Giuliano, A. R., Franceschi, R. T., & Wood, R. J. (1991) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(91)90358-p · Cited by 127
Influence of Passive Permeability on Apparent P-glycoprotein Kinetics
Lentz, K. A., Polli, J. W., Wring, S. A., Humphreys, J. E., & Polli, J. E. (2000) · Pharmaceutical Research · doi:10.1023/a:1007692622216 · Cited by 126
Permeability, Transport, and Metabolism of Solutes in Caco-2 Cell Monolayers: A Theoretical Study
Sun, H., & Pang, K. S. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.015321 · Cited by 124
Self-citationEvidence for Different ABC-Transporters in Caco-2 Cells Modulating Drug Uptake
Gutmann, H., Fricker, G., Török, M., Michael, S., Beglinger, C., & Drewe, J. (1999) · Pharmaceutical Research · doi:10.1023/a:1018825819249 · Cited by 121
Münzel, P., Schmohl, S., Heel, H., Kälberer, K., Bock-Hennig, B. S., & Bock, K. W. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15251-8 · Cited by 119
Luo, F., Paranjpe, P. V., Guo, A., Rubin, E. H., & Sinko, P. J. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.7.763 · Cited by 116
Predicting P-glycoprotein substrates by a quantitative structure–activity relationship model
Gombar, V. K., Polli, J. W., Humphreys, J. E., Wring, S. A., & Serabjit‐Singh, C. J. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20035 · Cited by 112
Hochman, J. H., Yamazaki, M., Ohe, T., et al. (2002) · Current Drug Metabolism · doi:10.2174/1389200023337559 · Cited by 110
Kalvass, J. C., & Pollack, G. M. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9135-x · Cited by 109
Cummins, C. L., Jacobsen, W., Christians, U., & Benet, L. Z. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.058065 · Cited by 108
Galijatovic, A., Otake, Y., Walle, U. K., & Walle, T. (2001) · Pharmaceutical Research · doi:10.1023/a:1011019417236 · Cited by 103
Are MDCK Cells Transfected with the Human MRP2 Gene a Good Model of the Human Intestinal Mucosa?
Tang, F., Horie, K., & Borchardt, R. T. (2002) · Pharmaceutical Research · doi:10.1023/a:1016192413308 · Cited by 91
Chirayath, M. V., Gajdzik, L., Hulla, W., Graf, J., Cross, H. S., & Peterlik, M. (1998) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1998.274.2.g389 · Cited by 88
Collett, A., Tanianis-Hughes, J., & Warhurst, G. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.05.006 · Cited by 86
Fisher, J. M., Wrighton, S. A., Watkins, P. B., Schmiedlin‐Ren, P., Calamia, J. C., Shen, D. D., Kunze, K. L., & Thummel, K. E. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38245-x · Cited by 86
Effect of bovine serum albumin on drug permeability estimation across Caco-2 monolayers
Saha, P., & Kou, J. H. (2002) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(02)00089-9 · Cited by 82
Cao, X., Yu, L. X., Barbaciru, C., Landowski, C. P., Shin, H., Gibbs, S. T., Miller, H. A., Amidon, G. L., & Sun, D. (2005) · Molecular Pharmaceutics · doi:10.1021/mp0499104 · Cited by 80
Naruhashi, K., Tamai, I., Inoue, N., Muraoka, H., Sai, Y., Suzuki, N., & Tsuji, A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.2.344-349.2002 · Cited by 76
Ochratoxin A secretion by ATP-dependent membrane transporters in Caco-2 cells
Schrickx, J. A., Lektarau, Y., & Fink‐Gremmels, J. (2005) · Archives of Toxicology · doi:10.1007/s00204-005-0041-5 · Cited by 76
Tran, T. T. T., Gales, T. L., Maleeff, B. E., Aldinger, T., Polli, J. W., Ayrton, A. D., Ellens, H. M., Bentz, J., & Mittal, A. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20105 · Cited by 74
Effect of changing intestinal flow rate on a measurement of intestinal permeability
Fine, K. D., Ana, C. A. S., Porter, J. L., & Fordtran, J. S. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90193-0 · Cited by 73
Taipalensuu, J., Tavelin, S., Lazorova, L., Svensson, A.-C., & Artursson, P. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(03)00204-5 · Cited by 71
In vitro and in vivo analysis of the mechanism of absorption enhancement by palmitoylcarnitine.
Hochman, J. H., Fix, J. A., & LeCluyse, E. L. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38767-7 · Cited by 70
Echchgadda, I., Song, C. S., Oh, T., Ahmed, M. R., Cruz, I. J. D. L., & Chatterjee, B. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0002 · Cited by 68
Fisher, J. M., Wrighton, S. A., Watkins, P. B., et al. (1999) · PubMed · Cited by 68
Peters, W., & Roelofs, H. M. J. (1989) · Biochemical Journal · doi:10.1042/bj2640613 · Cited by 66
Shirasaka, Y., Kawasaki, M., Sakane, T., Omatsu, H., Moriya, Y., Nakamura, T., Sakaeda, T., Okumura, K., Langguth, P., & Yamashita, S. (2006) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.21.414 · Cited by 65
Shimakura, J., Terada, T., Saito, H., Katsura, T., & Inui, K. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00171.2006 · Cited by 63
Tsuda, M., Terada, T., Irie, M., Katsura, T., Niida, A., Tomita, K., Fujii, N., & Inui, K. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.102830 · Cited by 61
Englund, G., Hallberg, P., Artursson, P., et al. (2004) · BMC Medicine · doi:10.1186/1741-7015-2-8 · Cited by 60
Bourdet, D. L., Pollack, G. M., & Thakker, D. R. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0204-y · Cited by 58
Mukherjee, T., Squillantea, E., Gillespieb, M., & Shao, J. (2004) · Drug Delivery · doi:10.1080/10717540490280345 · Cited by 54
Expression and localization of organic cation/carnitine transporter OCTN2 in Caco-2 cells
Elimrani, I., Lahjouji, K., Seidman, E. G., Roy, M.-J., Mitchell, G. A., & Qureshi, I. A. (2003) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00220.2002 · Cited by 53
LEVOTHYROXINE UP-REGULATES P-GLYCOPROTEIN INDEPENDENT OF THE PREGNANE X RECEPTOR
Mitin, T., Moltke, L. L., Court, M. H., & Greenblatt, D. J. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.32.8.779 · Cited by 52
Taurodeoxycholate modulates apical Cl-/OH- exchange activity in Caco2 cells
Alrefai, W. A., Saksena, S., Tyagi, S., Gill, R. K., Ramaswamy, K., & Dudeja, P. K. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-9090-8 · Cited by 51
Paine, M. F., Leung, L. Y., Lim, H., Liao, K., Oganesian, A., Zhang, M.-Y., Thummel, K. E., & Watkins, P. B. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.1.174 · Cited by 49
Bareis, P., Kállay, E., Bischof, M. G., Bises, G., Hofer, H., Pötzi, C., Manhardt, T., Bland, R., & Cross, H. S. (2002) · Experimental Cell Research · doi:10.1006/excr.2002.5528 · Cited by 49
Döppenschmitt, S., Spahn-Langguth, H., Regårdh, C. G., & Langguth, P. (1998) · Pharmaceutical Research · doi:10.1023/a:1011965707998 · Cited by 47
Okuwaki, M., Takada, T., Iwayanagi, Y., Koh, S., Kariya, Y., Fujii, H., & Suzuki, H. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9163-6 · Cited by 47
Effects of budesonide on P‐glycoprotein expression in intestinal cell lines
Maier, A. E., Zimmermann, C., Beglinger, C., Drewe, J., & Gutmann, H. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706992 · Cited by 43
Efflux properties of basolateral peptide transporter in human intestinal cell line Caco-2
Irie, M., Terada, T., Okuda, M., & Inui, K. (2004) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-004-1326-x · Cited by 43
Wenzel, U., Kuntz, S., Diestel, S., & Daniel, H. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.5.1375-1380.2002 · Cited by 43
Takara, K., Takagi, K., Tsujimoto, M., Ohnishi, N., & Yokoyama, T. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00922-7 · Cited by 40
Brimer, C., Dalton, J. T., Zhu, Z., Schuetz, J. D., Yasuda, K., Vanin, E. F., Relling, M. V., Lu, Y. W., & Schuetz, E. G. (2000) · Pharmaceutical Research · doi:10.1023/a:1007599923694 · Cited by 38
Construction of a Functional Transporter Analysis System Using MDR1 Knockdown Caco-2 Cells
Watanabe, T., Onuki, R., Yamashita, S., Taira, K., & Sugiyama, Y. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-5270-z · Cited by 36
Tam, D., Sun, H., & Pang, K. S. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.10.1214 · Cited by 35
Self-citationSaito, H., Motohashi, H., Mukai, M., & Inui, K. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7129 · Cited by 34
Hartley, D. P., Dai, X., Yabut, J. A., Chu, X., Cheng, O., Zhang, T., He, Y. D., Roberts, C., Ulrich, R. G., Evers, R., et al. (2006) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000220561.59972.7a · Cited by 33
Sun, H., Li, Z., Chow, E. C. Y., Lin, G., Zuo, Z., & Pang, K. S. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.137463 · Cited by 32
Self-citationNew Insights into Drug Absorption
Paine, M. F., Leung, L. Y., & Watkins, P. B. (2004) · Therapeutic Drug Monitoring · doi:10.1097/00007691-200410000-00001 · Cited by 30
Huin‐Schohn, C., Schohn, H., Hatier, R., Bentéjac, M., Antunes, L., Plénat, F., Bugaut, M., & Dauça, M. (2002) · Biology of the Cell · doi:10.1016/s0248-4900(01)01178-9 · Cited by 27
Romero, L., Higgins, M. A., Gilmore, J., Boudreau, K., Maslen, A., Barker, H. J., & Kirby, G. M. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.11.1186 · Cited by 23
Chen, X., Maiti, S., Zhang, J., & Chen, G. (2006) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.20149 · Cited by 21
Watanabe, K., Jinriki, T., & Sato, J. (2004) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.27.559 · Cited by 11
Cited by
The Impact of Food Bioactives on Health
(2015) · Springer eBooks · doi:10.1007/978-3-319-16104-4 · Cited by 805
Role of nanoparticle size, shape and surface chemistry in oral drug delivery
Banerjee, A., Qi, J., Gogoi, R., Wong, J., & Mitragotri, S. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.07.051 · Cited by 773
Safety Assessment of Graphene-Based Materials: Focus on Human Health and the Environment
Fadeel, B., Bussy, C., Merino, S., Vázquez, E., Flahaut, E., Mouchet, F., Evariste, L., Gauthier, L., Koivisto, A. J., Vogel, U., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b04758 · Cited by 671
The Toxicity Data Landscape for Environmental Chemicals
Judson, R., Richard, A., Dix, D. J., Houck, K., Martin, M., Kavlock, R., Dellarco, V., Henry, T., Holderman, T., Sayre, P., et al. (2009) · Environmental Health Perspectives · doi:10.1289/ehp.0800168 · Cited by 508
The Intestinal Barrier and Current Techniques for the Assessment of Gut Permeability
Schoultz, I., & Keita, Å. V. (2020) · Cells · doi:10.3390/cells9081909 · Cited by 467
Metadata
- Authors
- Sun, H., Chow, E. C., Liu, S., Du, Y., & Pang, K. S.
- Venue
- Expert Opinion on Drug Metabolism & Toxicology
- Publisher
- Informa UK Limited
- Published
- 2008-04
- Volume
- 4
- Issue
- 4
- Pages
- 395-411
- ISSN
- 1742-5255 (ISSN-L)
- 1744-7607
- OpenAlex
- W1994470556
- Cited by
- 527
- References
- 101
- FWCI
- 4.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.